CMS Extends Medicares Short-Term Bridge Program for GLP-1 Obesity Drug Coverage The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on January 1, 2027
Illustration of the weibull shape parameter signal detection tool using electronic healthcare record data
Semaglutide in Peripheral Artery Disease: A Step Toward Sex-Specific Care [PMID: 41224404] Laboratory literature summary: Semaglutide in Peripheral Artery Disease: A Step Toward Sex-Specific Care
de Vos CC, Meier K, Zaalberg PB, Nijhuis HJ, Duyvendak W, Vesper J, et al
Your skin deserves more than trial-and-error creams
All the ladies at Kalos are so amazing